Literature DB >> 23351844

Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.

Andreas Joosten1, Oscar Matzinger, Wendy Jeanneret-Sozzi, François Bochud, Raphaël Moeckli.   

Abstract

BACKGROUND AND
PURPOSE: To make a comprehensive evaluation of organ-specific out-of-field doses using Monte Carlo (MC) simulations for different breast cancer irradiation techniques and to compare results with a commercial treatment planning system (TPS).
MATERIALS AND METHODS: Three breast radiotherapy techniques using 6MV tangential photon beams were compared: (a) 2DRT (open rectangular fields), (b) 3DCRT (conformal wedged fields), and (c) hybrid IMRT (open conformal+modulated fields). Over 35 organs were contoured in a whole-body CT scan and organ-specific dose distributions were determined with MC and the TPS.
RESULTS: Large differences in out-of-field doses were observed between MC and TPS calculations, even for organs close to the target volume such as the heart, the lungs and the contralateral breast (up to 70% difference). MC simulations showed that a large fraction of the out-of-field dose comes from the out-of-field head scatter fluence (>40%) which is not adequately modeled by the TPS. Based on MC simulations, the 3DCRT technique using external wedges yielded significantly higher doses (up to a factor 4-5 in the pelvis) than the 2DRT and the hybrid IMRT techniques which yielded similar out-of-field doses.
CONCLUSIONS: In sharp contrast to popular belief, the IMRT technique investigated here does not increase the out-of-field dose compared to conventional techniques and may offer the most optimal plan. The 3DCRT technique with external wedges yields the largest out-of-field doses. For accurate out-of-field dose assessment, a commercial TPS should not be used, even for organs near the target volume (contralateral breast, lungs, heart).
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23351844     DOI: 10.1016/j.radonc.2012.11.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  20 in total

1.  A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy.

Authors:  Lydia J Jagetic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2015-06-04       Impact factor: 3.609

2.  Deep inspiration breath-hold (DIBH) radiotherapy in left-sided breast cancer: Dosimetrical comparison and clinical feasibility in 20 patients.

Authors:  Rodrigo Hepp; Mark Ammerpohl; Christina Morgenstern; Lisa Nielinger; Patricia Erichsen; Abdallah Abdallah; Razvan Galalae
Journal:  Strahlenther Onkol       Date:  2015-04-18       Impact factor: 3.621

3.  Measurement and modeling of out-of-field doses from various advanced post-mastectomy radiotherapy techniques.

Authors:  Jihyung Yoon; David Heins; Xiaodong Zhao; Mary Sanders; Rui Zhang
Journal:  Phys Med Biol       Date:  2017-11-13       Impact factor: 3.609

4.  Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studies.

Authors:  Choonik Lee; Jae Won Jung; Christopher Pelletier; Anil Pyakuryal; Stephanie Lamart; Jong Oh Kim; Choonsik Lee
Journal:  Phys Med Biol       Date:  2015-02-26       Impact factor: 3.609

5.  Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk.

Authors:  Iga Racka; Karolina Majewska; Janusz Winiecki
Journal:  Strahlenther Onkol       Date:  2022-08-09       Impact factor: 4.033

6.  Calculating and estimating second cancer risk from breast radiotherapy using Monte Carlo code with internal body scatter for each out-of-field organ.

Authors:  Takeshi Takata; Kenshiro Shiraishi; Shinobu Kumagai; Norikazu Arai; Takenori Kobayashi; Hiroshi Oba; Takahide Okamoto; Jun'ichi Kotoku
Journal:  J Appl Clin Med Phys       Date:  2020-10-30       Impact factor: 2.102

7.  Accelerated partial breast irradiation with intensity-modulated radiotherapy is feasible for chinese breast cancer patients.

Authors:  Zhenyu He; Sangang Wu; Juan Zhou; Fengyan Li; Jiayan Sun; Qin Lin; Huanxin Lin; Xunxing Guan
Journal:  J Breast Cancer       Date:  2014-09-30       Impact factor: 3.588

8.  Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.

Authors:  C Simonetto; H Rennau; J Remmele; S Sebb; P Kundrát; M Eidemüller; U Wolf; G Hildebrandt
Journal:  Strahlenther Onkol       Date:  2018-10-22       Impact factor: 3.621

9.  Development of clinical application program for radiotherapy induced cancer risk calculation using Monte Carlo engine in volumetric-modulated arc therapy.

Authors:  Dong-Jin Kang; Young-Joo Shin; Seonghoon Jeong; Jae-Yong Jung; Hakjae Lee; Boram Lee
Journal:  Radiat Oncol       Date:  2021-06-12       Impact factor: 3.481

10.  SUV39H1 downregulation induces deheterochromatinization of satellite regions and senescence after exposure to ionizing radiation.

Authors:  Corinne Sidler; Dongping Li; Bo Wang; Igor Kovalchuk; Olga Kovalchuk
Journal:  Front Genet       Date:  2014-11-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.